Partner Article
Croda buy majority stake in Chinese chemicals firm
Snaith-headquartered chemical firm, Croda International, has received regulatory approval to buy a 65% stake in Chinese chemical manufacturers, Sichuan Sipo Chemical Co. Ltd.
The majority stake will be acquired from Sichuan Forever Holding Co. Ltd and individual shareholders for £38.2m.
Sipo employs around 300 people in the Sichuan province and produces speciality derivatives from natural raw materials.
The firm reported turnover of £28.0m and EBITDA of £3.1m last year.
This acquisition is intended to strengthen Croda’s credentials in the international fatty acid amides market, and products will be sold through Croda’s sales operation.
Steve Foots, chief executive of Croda, commented: “This is a significant step forward in our strategy to increase Croda’s presence in fast growing and emerging markets. Sipo’s manufacturing capabilities together with our marketing expertise and sales force infrastructure are an exciting combination.
“We will have a stronger platform in niche markets and renewable technologies which will allow us to develop our customer base and drive sales growth in Asia. Our broader footprint in China will also enable us to be more responsive to customer needs in this important region.”
This was posted in Bdaily's Members' News section by Tom Keighley .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular Yorkshire & The Humber morning email for free.
Who speaks up for SMEs when giants get bigger?
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs
Business success starts with people investment
It's time to confront the digital poverty crisis
Why a business exit is no longer all or nothing
Culture is the foundation for sustainable growth
Business must help young people take root in work
Purposeful procurement for long-term growth
Time to rethink outdated views on apprenticeships
The scale-ups rocketing through our fast world
Care about the experience, not just the outcome